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Weight regain is one of the most common problems in the long-term after bariatric surgery. It is 
unknown if high-intensity exercise programs applied in late phases of post-surgical follow-up could 
counteract this trend. After a 3-year follow-up, 21 patients underwent sleeve gastrectomy were 
randomized into an exercise group (EG, n = 11), that performed a 5-month supervised exercise program, 
and a control group (CG, n = 10), that followed the usual care. Body composition, cardiorespiratory 
fitness, glycaemia and blood cholesterol were evaluated before and after the intervention. Finally, the 
EG repeated the evaluations 2 months after the end of the exercise program. Both groups reached their 
maximum weight loss at the first year after surgery and showed significant weight regain by the end 
of the follow-up. After the exercise program, the EG showed reductions in fat mass (−2.5 ± 2.6  kg, 
P < 0.05), glycaemia (−13.4 ± 8.7  mg·dL−1, P < 0.01) and blood cholesterol (−24.6 ± 29.1  mg·dL−1, 
P < 0.05), whereas the CG during the same period showed increases in weight (1.5 ± 1.3  kg, P < 0.05) 
and fat mass (1.8 ± 0.9, P < 0.01). Two months after the end of the program, EG had increases in weight 
(1.1 ± 1.2  kg, P < 0.05), fat mass (2.6 ± 2.2  kg, P < 0.01), glycaemia (8.2 ± 11.6  mg·dL−1, P < 0.05) and 
blood cholesterol (20.0 ± 22.1  mg·dL−1, P < 0.05), when compared with the values after the exercise 
program. Therefore, in the medium-term after sleeve gastrectomy exercise may contribute to prevent 
weight regain and to reduce fat mass, glycaemia, and blood cholesterol.
Bariatric surgery (BS) is considered successful when patients reach 50% or more of their excess weight loss (EWL) 
and achieve a body mass index (BMI) below 35  kg·m−21. In the short-term follow-up, BS has been shown to be 
very effective in generating weight loss and improvements in obesity-related comorbidities and cardio-metabolic 
risk factors2. However, in the long-term (≥5 years) follow-up studies, a weight regain phase has been described 
for some bariatric techniques, being one of the greatest problems mainly after restrictive procedures3. Several 
studies have reported up to 58.5% of weight regain in patients undergoing sleeve gastrectomy4–6. As a conse-
quence, the percentage of excess weight loss (%EWL) decreases over time7 and after 5 or more years after surgery, 
between 32% and 64% of patients are below 50% of EWL8,9. This weight regain, besides leading in some cases to a 
revisional surgery (15.4–36% of patients)5,6, may also be accompanied by an increase in comorbidities10.
Several reasons have been suggested to explain weight regain after sleeve gastrectomy, such as a greater resid-
ual gastric volume11, or maladaptive eating behaviours4,12,13. However, physical activity seems to play a relevant 
role in this regard. After BS, physical activity levels increase13,14, which is associated with increases in %EWL15. 
However, over time, physical activity levels tend to decrease16, which can contribute to weight regain. It has been 
demonstrated that bariatric patients who performed some physical activity had a lower incidence of weight regain 
than sedentary subjects4. Few studies, mostly observational, have analysed the role of physical activity in weight 
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regain, reporting associations between a sedentary lifestyle and weight regain4. Similarly, in the long-term, the 
effects of exercise on cardio-metabolic risk factors and on the quality of life still remain unclear.
Therefore, the aim of the present study was to analyse the effects of a supervised and customized exercise 
program that combined endurance and resistance training, initiated at moderate intensity and progressing to 
high intensities applied 3 years after sleeve gastrectomy. The primary outcome was the effect on weight regain 
and body composition. Additional secondary outcomes were the effects on physical fitness, cardiovascular risk 
(CVR) and quality of life.
Results
Participants. Two patients declined to participate in the study after initial interview. During the follow-up, 
19 patients were lost, and 21 were enrolled at the intervention. Of these patients, 11 patients were allocated in the 
exercise group (EG; 72.7% women) and 10 patients were allocated in the control group (CG; 80% women). Data 
from two of the patients from the CG that were lost during the follow-up, and from one of the patients that failed 
to complete ≥85% of the intervention were excluded of the statistical analyses (Fig. 1). No significant differences 
between both groups were noticed at baseline (Table 1).
Body composition and anthropometric measures. The EG obtained its maximum decrease of total 
fat mass and body fat percentage 7 months after BS, whereas the CG did so 13 months after surgery. Both groups 
reached their maximum reduction of total weight and their maximum increase of %EWL by 13 months after 
surgery. Compared to that moment, weight loss, total fat mass (FM), and fat mass percentage (%FM), significant 
increased by 37 months after BS in both groups, in addition to a significant decrease of %EWL. This was paralleled 
by a significant reduction of fat free mass (FFM) at 37 months after surgery for the EG, and 19 months after BS 
for the CG (Fig. 2).
Changes in body composition and anthropometric measures after the exercise program are summarized in 
Table 2. After the intervention, the EG had significant reductions in total fat mass and fat mass percentage, show-
ing a tendency to reduce the total weight and waist circumference, and to increase %EWL and FFM (Fig. 2). In 
contrast, the CG had a significant increase in total weight, fat mass and fat mass percentage, and significant reduc-
tion in %EWL. Before and after the intervention (37–42 months after BS), significant differences were observed 
between groups in the changes of all body composition and anthropometric measures except in hip circumfer-
ence and FFM. However, FFM showed a large change between groups (d = 0.96). Forty-two months after surgery, 
Figure 1. CONSORT flow diagram during the study. Two participants from the control group were lost, and 
one participant in the experimental group failed to complete the program due to a lesion unrelated to the 
intervention.
3Scientific RepoRtS |         (2020) 10:3123  | https://doi.org/10.1038/s41598-020-60044-z
www.nature.com/scientificreportswww.nature.com/scientificreports/
in the CG there were no significant differences in the fat mass percentage when compared with one month after 
BS, nor differences in the FFM of the EG compared to one month after surgery (Supplementary material).
Two months after the exercise program -i.e., between 42 and 44 months after BS-, the EG returned to exhibit 
weight regain, with increased fat mass and fat mass percentage, as well as decreased %EWL and FFM (Fig. 2).
Cardio-metabolic risk factors and cardiorespiratory fitness. After the exercise program, the EG 
showed a significant reduction in blood glucose (75.9 ± 29.4 vs. 62.5 ± 13.6  mg·dL−1; P = 0.005, 95% CI: −19.6, 
−7.1) and total cholesterol (212.0 ± 49.9 vs. 187.4 ± 39.4  mg·dL−1; P = 0.026, 95% CI: −45.4, −3.8). In addi-
tion, the EG showed a small tendency to decrease systolic (132.5 ± 23.4 vs. 127.0 ± 20.2  mmHg; d = 0.25, 95% 
CI: −26.11, 15.05) and diastolic blood pressure (78.2 ± 9.3 vs. 75.1 ± 9.9  mmHg; d = 0.25, 95% CI: −14.9, 8.7), 
as well as CVR (1.7 ± 0.95 vs. 1.4 ± 0.70; d = 0.36, 95% CI: −1.08, 0.48). Between 37 months and 42 months, 
waist-to-height ratio had significant difference between groups (P = 0.033, 95% CI: −0.61, −0.01) (Table 2). 
Two months after the end of the exercise program (44 months after surgery), total cholesterol increased to 
207.40 ± 51.0  mg·dL−1 (P = 0.019, 95% CI: 4.2, 35.8) and blood glucose to 70.7 ± 10.4  mg·dL−1 (P = 0.047, 95% 
CI: −3.2, 19.6) in the EG. Furthermore, at 44 months after BS increases in waist-to-height ratio (P = 0.004, 95% 
CI: 0.01, 0.02), CVR (d = 0.37, 95% CI: −0.38, 0.82), and diastolic blood pressure (d = 0.31, 95% CI: −7.6, 14.5) 
were observed in the EG.
Positive correlations were also observed between reductions in total weight and fat mass with reductions 
in cholesterol (r = 0.744, P = 0.014; r = 0.719, P = 0.019, respectively) and CVR (r = 0.808, P = 0.005; r = 0.679, 
P = 0.031, respectively), as well as between reductions in total weight and reductions in systolic blood pressure 
(r = 0.844, P = 0.002), after the intervention.
After the exercise program (42 months after surgery), the EG obtained significant improvements of absolute 
(1.7 ± 0.48 vs. 2.0 ± 0.67  l∙min−1; P = 0.005, 95% CI: 0.11, 0.47) and relative VO2peak (19.8 ± 3.4 vs. 23.2 ± 4.6 
ml∙kg−1 ∙ min−1; P = 0.002, 95% CI: 1.66, 5.1).
Quality of life. After the intervention, the absolute change in bodily pain increased in the EG in comparison 
with the CG (Table 3). Additionally, in the EG changes in most of the components of the SF-36 showed medium 
to large effects sizes after the exercise program: role physical (d = 0.33, 95% CI: −35.2, 66.5), social functioning 
(d = 0.40, 95% CI: −15.8, 34.6), mental health (d = 0.63, 95% CI: −8.77, 33.8), vitality (d = 0.69, 95% CI: −7.69, 
35.2), physical component summary (d = 0.55, 95% CI: −5.6, 17.9), and bodily pain (d = 1.04, 95% CI: −0.8, 
54.5). In contrast, in the CG, there were no changes in most scales of the questionnaire. Only a decrease in 
the mental component summary (d = 0.72, 95% CI: −21.63, 4.26) and a small reduction in social functioning 
(d = 0.30, 95% CI: −49.0, 28.0) were found.
Discussion
The effectiveness of BS on weight loss has been widely demonstrated. However, its effects are limited in time, and 
weight regain is a common complication in bariatric patients, mainly after restrictive procedures. In the litera-
ture, a dramatic increase in %EWL in the first months after surgery as well as a reduction of the FFM have been 
described17. Afterwards, weight loss slows down, until a point of maximum weight loss is reached between 12 and 
24 months after surgery3,5. Nevertheless, decreases of %EWL from 56% to 46% have been reported in subjects 
submitted to sleeve gastrectomy between 12 and 36 months after surgery18. In the same way, other studies have 
observed significant weight regain between 24 and 36 months19, and between 24 and 48 months after surgery3. 
Our data are in accordance with these previous observations. In our sample, the large increase in %EWL during 
the first months was followed by a small increase until month 13 after surgery, when the highest %EWL was 
reached. At this time-point, a reduction of %EWL began, causing a significant weight regain in both groups at 37 
months after surgery.
Unfortunately, there are few studies in the literature in which body composition has been measured in the 
long-term. To our knowledge, most studies have measured body composition between 6 and 24 months after 
surgery. According to these studies, a biphasic loss of fat mass can be observed: an initial fast phase of fat mass 
reduction during the first year after surgery, that is followed by a second phase in which fat loss slows down until 
it reaches a point of maximum fat mass loss at month 2420. However, studies that have a longer follow-up period 
Baseline At month 37 postoperatively
Total (n = 18) CG (n = 8) EG (n = 10) Total (n = 18) CG (n = 8) EG (n = 10)
Age (years) 45.7 ± 8.9 43.7 ± 11.4 47.3 ± 6.5 48.7 ± 8.9 46.4 ± 11.2 50.6 ± 6.6
Weight (kg) 101.9 ± 18.8 98.4 ± 18.0 104.7 ± 19.8 89.0 ± 19.5 84.6 ± 15.9 92.5 ± 22.2
BMI (kg·m-²) 38.6 ± 4.8 38.2 ± 5.1 38.9 ± 4.8 33.7 ± 5.9 32.8 ± 4.3 34.4 ± 7.0
Fat mass (%) 43.9 ± 5.9 43.5 ± 5.8 44.2 ± 6.2 38.5 ± 8.9 37.5 ± 8.8 39.4 ± 9.3
Fat mass (kg) 45.1 ± 12.1 42.9 ± 9.5 46.9 ± 14.0 35.3 ± 14.6 32.3 ± 10.8 37.7 ± 17.1
Fat free mass (%) 56.1 ± 5.9 56.5 ± 5.8 55.8 ± 6.2 61.5 ± 8.9 62.5 ± 8.8 60.6 ± 9.3
Fat free mass (kg) 56.8 ± 10.1 55.5 ± 12.1 57.7 ± 8.7 53.7 ± 9.5 52.3 ± 9.8 54.8 ± 9.7
Female (%) 77.8 87.5 70.0 77.8 87.5 70.0
Table 1. Baseline characteristics of participants that completed the study. Data at the beginning of the follow-up 
(1 month after surgery), and at the start of the exercise program (37 months after surgery). CG, control group; 
EG, exercise group; BMI, body mass index.
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showed a tendency to recover fat mass21,22. Similar to these reports, in the present study, patients reached their 
maximum fat loss between month 7 and 13 months after surgery. From this moment onwards, an increase in fat 
mass was observed in both groups, being significantly higher 37 months after surgery. Additionally, significant 
losses of FFM were observed in both groups.
Figure 2. Changes in body mass (A), fat mass (B), fat-free mass (C), excess weight loss (D), waist 
circumference (E) and waist to height ratio (F) during the follow-up. The vertical dotted lines at 37 and 42 weeks 
mark the 5-month exercise intervention (EX). Data represent mean ± SEM. Data for the experimental group 
(EG) are indicated as black dots and continuous lines. Data for the control group (CG) are indicated as open 
dots and dotted lines. Statistical comparisons correspond to intragroup t-tests among the indicated time points. 
Horizontal continuous lines indicate the time points compared in the EG, while horizontal dotted lines indicate 
the time points compared in the CG. *p < 0.05; **p < 0.01. At the beginning of the intervention (EX) body 
mass (A) was significantly higher than after surgery, and this was due to the regain of fat mass (B) and a trend 
to lose fat-free mas (C). Consequently, at the beginning of the intervention a significant reduction of excess 
weight loss (D) was observed in both groups in comparison with its maximal value, reached approximately one 
year after surgery. This was accompanied by an increase of various cardiovascular risk factor (E,F). In the EG 
the intervention contributed to counteract the progressive increase in fat mass (B) and the decline in EWL (D) 
seen in the CG. Body mass was not significantly reduced during the intervention in the EG (A), possibly due to 
the trend to increasing the fat-free mass in this group caused by the intervention (C). Similarly, the intervention 
tended to improve the cardiovascular risk factors in the EG (E,F). All of these effects seem to be caused directly 
by the exercise program, since they significantly varied in the opposite direction in the retention evaluation, two 
months after ending the intervention.
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Several mechanisms may contribute to the weight regain after BS. On the one hand, the decrease of leptin and 
insulin levels may, in turn, generate a greater appetite sensation23. In this regard, a progressive increase in energy 
intake24 has been reported in BS patients over time. Poor eating habits12 as well as an increase of the gastric cav-
ity11 may contribute to this effect after sleeve gastrectomy. On the other hand, weight loss also leads to a reduction 
of basal metabolic rate25, which may be an important component after BS, since associations have been found 
between low basal metabolic rate and weight regain26.
According to the results of the present study, individualized and supervised exercise programs may be con-
sidered as adjuvant interventions to prevent weight regain in the long-term after sleeve gastrectomy. Our data 
showed significant reductions in fat mass and fat mass percentage, a trend towards total weight reduction and an 
increase of %EWL and FFM in the EG, at the end of the exercise program. However, during the corresponding 
time after surgery, in the CG weight, fat mass and fat mass percentage continued to increase significantly, while 
significant reductions of %EWL occurred. This resulted in fat mass reaching similar values to the preoperative 
ones in the CG at 42 months after surgery.
Unfortunately, studies found in the literature on this topic are scarce and mostly observational. These studies 
have shown positive associations between low levels of self-reported physical activity13, a sedentary lifestyle4 and 
sitting time with weight regain27, as well as that subjects who performed one or more weekly sessions of physical 
activity had a lower weight regain27. To the best of our knowledge, only an experimental study performed a phys-
ical exercise program in the medium-term after BS. This study was conducted in patients with a BMI greater than 
30  kg·m−2 12–24 months after surgery, reporting weight and fat mass reductions only in the exercise group, while 
in the control group these variables increased28. However, in contrast with our data, a trend to decrease FFM 
was observed. This difference may be explained by the introduction of resistance training of controlled intensity 
(≥70% RM) in our intervention. This shows the effectiveness and necessity of resistance training at high intensi-
ties in bariatric patients, since an increase in FFM leads to an increase in the basal metabolic rate, which can help 
to prevent weight regain.
Two months after the end of the exercise program, significant increases in total weight and fat mass and sig-
nificant reductions of %EWL and FFM were observed in the EG. Therefore, the benefits of the exercise program 
were not retained after its ending. Weight recovery after a program of weight loss has been previously related to 
the reduction of physical activity in patients with obesity29. In fact, it has been concluded that physical activity is 
a determining factor in the maintenance of weight loss30. Our data support this argument.
Sleeve gastrectomy induces a reduction in CVR factors2. Although these reductions tend to persist in the 
long-term, there is a proportion of patients in which improvements in comorbidities tend to be attenuated10. For 
example, relapse in type 2 diabetes mellitus is a common complication, with relapse rates ranging from 19% to 
35.1%31,32. In addition, type 2 diabetes mellitus relapses have been associated with weight regain32,33. Our results 












Weight (kg) EG 92.5 ± 22.2 91.3 ± 21.5 0.195 −1.2 ± 2.6 (−3.07, 0.72) 0.018
CG 84.6 ± 15.9 86.1 ± 15.6 0.015 1.5 ± 1.3 (0.41, 2.66)
BMI (kg·m−²) EG 34.4 ± 7.0 33.9 ± 6.7 0.191 −0.45 ± 1.0 (−1.18, 0.27) 0.017
CG 32.8 ± 4.3 33.4 ± 4.3 0.017 0.62 ± 0.56 (0.15, 1.09)
EWL (%) EG 54.5 ± 22.8 56.6 ± 22.4 0.211 2.1 ± 5.0 (−1.43, 5.66) 0.013
CG 57.6 ± 25.6 53.8 ± 27.0 0.022 − 3.8 ± 3.6 (−6.82, 0.72)
FM (kg) EG 37.7 ± 17.1 35.2 ± 16.3 0.013 −2.5 ± 2.6 (−4.41, 0.66) 0.000
CG 32.3 ± 10.8 34.1 ± 10.5 0.001 1.8 ± 0.9 (1.01, 2.61)
FM (%) EG 39.4 ± 9.3 37.2 ± 9.8 0.005 −2.1 ± 1.8 (−3.45, 0.81) 0.013
CG 37.5 ± 8.8 39.0 ± 8.05 0.010 1.5 ± 1.23 (0.49, 2.55)
FFM (kg) EG 54.8 ± 9.7 56.1 ± 11.0 0.072 1.4 ± 2.1 (−0.14, 2.88) 0.069
CG 52.3 ± 9.8 52.0 ± 9.5 0.538 −0.3 ± 1.2 (−1.29, 0.74)
FFM (%) EG 60.6 ± 9.3 62.8 ± 9.8 0.005 2.1 ± 1.8 (0.82, 3.46) 0.000
CG 62.5 ± 8.8 61.0 ± 8.0 0.010 −1.5 ± 1.2 (−2.55, −0.49)
Waist (cm) EG 103.6 ± 11.0 101.6 ± 12.2 0.227 −1.9 ± 4.9 (−5.49, 1.49) 0.035
CG 98.2 ± 17.9 101.1 ± 16.6 0.072 2.8 ± 3.8 (−0.34, 6.1)
Hip (cm) EG 116.1 ± 19.2 116.0 ± 18.4 0.864 −0.152 (−2.09, 1.79) 0.305
CG 113.3 ± 11.3 114.3 ± 11.2 0.126 1.01 (−0.36, 2.38)
WtHR EG 0.634 ± 0.06 0.621 ± 0.062 0.223 −0.013 ± 0.03 (−0.03, −0.001) 0.033
CG 0.617 ± 0.101 0.637 ± 0.101 0.077 0.019 ± 0.26 (−0.003, 0.041)
Table 2. Changes in body composition and anthropometric data after exercise program. Data are mean ± SD. 
95% confidence intervals in brackets. BMI, body mass index; EWL, excess weight loss; FM, fat mass; FFM, fat 
free mass; WtHR, waist-to-height ratio; EG, exercise group; CG, control group. Note: a37 months after surgery; 
b42 months after surgery.
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cholesterol, reductions were also relevant from a clinical point of view as cholesterol levels ranged into a desirable 
zone (<200  mg·dl−1)34 after the intervention.
Exercise contributes to the observed CVR factors reductions. Both endurance and resistance training trigger 
a large uptake of glucose in the skeletal muscle35. High intensity interval training (HIIT) seems to be of great 
importance, since it causes a higher glucose uptake than moderate intensity training36. This can be explained by 
different mechanisms. First, HIIT increases the sarcolemmal translocation of the glucose transporter GLUT437. 
Additionally, HIIT increases skeletal muscle oxidative capacity38, which is impaired in subjects with obesity39. 
This may increase insulin sensitivity, since there is an association between both40. Therefore, HIIT may contribute 
to a reduction in hyperglycaemia38 and insulin resistance41. In addition, the exercise program provoked reduc-
tions in waist circumference and waist-to-hip ratio. Taken together, all these effects are of great importance, since 
they are associated with cardio-metabolic risk42.
Along with these physiological responses, improvements were observed in the quality of life of participants 
who performed the exercise program, especially in the physical scales of the SF36 questionnaire. Many stud-
ies have reported short-term improvements in quality of life after BS, both in the physical and mental scales43. 
However, these effects are lost in the long-term, especially in the physical domains44,45. The results of the present 
study show that exercise can reverse this trend, improving the participant’s quality of life, particularly in the 
physical components.
Additionally, other studies have shown that between the 1st and 3rd year after surgery bodily pain increases 
in BS patients44. Our data have shown a reduction of bodily pain in the participants in the exercise program. 
This result can be due to the addition of two factors: weight loss and resistance training, which generates a lower 
mechanical load and provides greater support and joint stability46.
Nevertheless, several limitations of the present study should be recognized. First, this study had a lack of nutri-
tional and physical activity control, and participants were only encouraged to follow the guidelines established 
by their hospital. Therefore, it is possible that subjects who lost weight, in addition to performing exercise would 
have changed their eating habits. Consequently, future works should test if these variables are affected by an 
exercise-based intervention like the one described here. Additionally, the small sample size may make it difficult 
to generalize our results.
In summary, our data show that a point of maximum weight loss and fat mass is reached 13 months after 
sleeve gastrectomy. From this moment on, a process of weight regain begins, until there is a significant recovery of 
weight and fat mass at 37 months after the surgery. An individualized and supervised combined exercise program 
as described in this study slows down this weight regain and generates a reduction of fat mass and a tendency to 
increase fat-free mass. Moreover, improvements in cardiorespiratory fitness, cardio-metabolic risk factors and in 
health-related quality of life are observed after the exercise program. These improvements disappear two months 
after the end of the exercise program. Therefore, our results show that exercise is an effective tool to avoid weight 
regain and relapse in cardio-metabolic risk even at long time after sleeve gastrectomy. Consequently, implemen-












EG 82.5 ± 21.7 86.9 ± 16.9 0.087 4.4 ± 6.2 (−0.83, 9.58) 0.121
CG 88.7 ± 12.2 86.2 ± 19.8 0.502 −2.5 ± 10.0 (−10.9, 5.86)
Role physical
EG 53.1 ± 50.8 68.7 ± 43.8 0.435 15.6 ± 53.3 (−29.0, 60.2) 0.276
CG 71.9 ± 41.0 65.6 ± 42.1 0.170 −6.2 ± 11.6 (−15.9, 3.42
Bodily pain
EG 44.5 ± 27.7 71.4 ± 23.7 0.089 26.9 ± 38.5 (−5.33, 59.1) 0.044
CG 61.4 ± 33.4 57.0 ± 34.7 0.268 − 4.4 ± 10.3 (−13.0, 4.22)
General health perceptions
EG 78.4 ± 18.7 82.5 ± 16.1 0.397 4.1 ± 13.0 (−6.68, 14,9) 0.454
CG 71.9 ± 17.5 72.2 ± 20.2 0.830 0.37 ± 4.7 (−3.59, 4.34)
Vitality
EG 65.6 ± 25.1 79.4 ± 12.9 0.118 13.7 ± 21.8 (−4.5, 32.0) 0.201
CG 60.0 ± 18.9 61.9 ± 19.6 0.678 1.8 ± 12.3 (−8.34, 12.1)
Social functioning
EG 78.1 ± 29.7 87.5 ± 14.9 0.442 9.3 ± 32.6 (−17.8, 36.6) 0.146
CG 76.6 ± 34.3 65.6 ± 38.2 0.133 −10.9 ± 18.2 (−26.2, 4.3)
Role emotional
EG 79.2 ± 39.6 75.0 ± 46.3 0.836 −4.2 ± 54.7 (−49.9, 41.6) 0.879
CG 50.0 ± 47.1 41.7 ± 49.6 0.668 −8.3 ± 52.7 (−52.4, 35.7)
Mental health
EG 75.0 ± 25.6 87.5 ± 11.4 0.250 12.5 ± 28.2 (−11.0, 36.0) 0.324
CG 67.0 ± 22.0 68.5 ± 23.7 0.723 1.5 ± 11.5 (−8.11, 11.1)
Physical component summary
EG 44.2 ± 9.9 50.0 ± 11.3 0.152 5.8 ± 0.10.2 (−2.74, 14.3) 0.165
CG 49.5 ± 8.1 50.0 ± 14.1 0.842 .57 ± 7.8 (−5.95, 7.1)
Mental component summary
EG 50.0 ± 13.9 51.6 ± 8.6 0.735 1.6 ± 12.5 (−8.91, 12.0) 0.270
CG 47.5 ± 8.0 39.3 ± 15.1 0.153 −8.7 ± 15.3 (−21.5, 4.13)
Table 3. Changes in SF-36 scores after exercise program. Data are mean ± SD. 95% confidence intervals in 
brackets. EG, exercise group; CG, control group. Note: a37 months after surgery; b42 months after surgery.
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Methods
Participants. A prospective randomized clinical trial (ClinicalTrials.gov number: NCT03603392; 
04/07/2018) was performed. A total of 40 patients who underwent sleeve gastrectomy during three consecu-
tive years in two university hospitals from an urban area (≈230000 inhabitants), were offered to join the study. 
Patients with previous cardiovascular diseases, history of cancer in the previous 5 years and functional limitations 
that prevented them from performing the exercise program were excluded from the study. All the patients signed 
an informed consent form to be included in the study. This study was conformed to the Declaration of Helsinki 
and approved by the University Miguel Hernández Ethics Committee. Group sizes were estimated to provide a 
statistical power of 0.80 with a significance level of 0.01, according to our previous experience with this popula-
tion and intervention47.
Design. Body composition and anthropometric measurements were assessed in all participants at 5 time-points 
(1, 7, 13, 19 and 37 months after surgery) before starting the intervention. At 37 months after BS, participants were 
randomized in two groups: an exercise group (EG; n = 11 patients coming from the twenty first patients that 
were operated on) and a control group (CG; n = 10 patients, coming from the resting twenty patients). Patients 
form both hospitals were included in each group. The EG performed a 5-months of supervised exercise program, 
while the CG followed the usual care. Measurements of cardiorespiratory fitness, biochemical parameters, body 
composition, anthropometry, blood pressure and health-related quality of life for the EG were performed. Body 
composition, anthropometry and health-related quality of life for the CG were also assessed. Data were collected at 
the start of the exercise program (37 months after BS) and at the end of the program (42 months after BS). Finally, 
the EG was evaluated 2 months after the end of the exercise program (44 months after BS).
Measurements were performed in a climatically controlled laboratory, located at 80  m above sea level, in 
which the relative air humidity was maintained between 45–60% and the temperature between 22–24 °C.
Exercise program. The exercise program lasted 20 weeks, which were distributed in five 4-week blocks 
(Table 4). All training sessions were performed in the sport facilities of our institution and supervised by gradu-
ates in sports sciences. The first block included two weekly sessions, in which endurance and resistance training 
for 5 muscle groups (hamstrings, pectorals, quadriceps, latissimus dorsi, and gastrocnemius) was combined in 
the same session. In the second block participants trained 3 days a week: in two of them a high-intensity interval 
training (HIIT) was performed, followed by resistance training (biceps and triceps were added to the previous 
5 major muscle groups trained), while in the third session only the endurance training was performed. Between 
the third and fifth block participants trained 4 days per week. In two sessions, a HIIT was performed, followed 
by resistance training, focusing on different muscle groups in each session: (a) session 1: pectorals, quadriceps, 
biceps, and hamstrings; (b) session 2: dorsal, triceps, gastrocnemius and deltoids. In the other two sessions, 
endurance training was performed. In all the blocks, 2 days a week of flexibility training were carried out.
The endurance training (performed either on cycle-ergometer, elliptical or treadmill) was monitored using 
a heart rate monitor (FT40, Polar, Finland). The resistance training was performed using resistance machines, 
and training intensity was determined by percentages of 1 maximum repetition which was estimated using the 
Brzycki formula48. The HIIT consisted of a five-minute warm up, increasing the intensity from 40% of VO2peak to 
60% VO2peak. After this, 20  minutes with bouts of 30  seconds at high intensity (60–95% VO2peak) and 30  seconds 
of active recovery (40% VO2peak), for a total of 10  minutes of training at high intensity were performed. Finally, 
3  minutes of cool-down at 40% VO2peak were performed. During the two last weeks of block 3, both the RM and 
the VO2peak were measured, and the intensities of the following sessions (blocks 4 and 5) were fixed according to 
these values.
Resistance training, HIIT and flexibility exercises were combined in the same session, in order to reach similar 
duration per session (roughly 50  min) to the continuous aerobic training.
Test measures. Body composition and anthropometric measures. Body composition and anthropometric 
measures were evaluated between 8:00–9:00 AM, after at least 10  hours of fasting. Alcohol consumption and 
physical activity were restricted for at least 8  hours before the test49 while physical activity was forbidden in 
the 48  hours prior to the test. Participants performed the assessment with an empty bladder49. Bioimpedance 
analysis (Tanita, TBF 300 A, Tokyo, Japan) was used to measure body weight and body composition. BMI was 
calculated and expressed as kg·m−2 50. The percentage of EWL was calculated according with the usual formula: 
%EWL = (initial weight − current weight)/(actual weight −(25 × height²)) × 100)51. The International Society 
for the Advancement of Kinanthropometry (ISAK) protocol52 was used to assess height as well as waist and hip 
circumferences.
Cardiorespiratory fitness. Cardiorespiratory fitness was evaluated between 4:00–8:00 PM. The peak oxygen 
uptake (VO2peak) was determined on a cycle ergometer (Technogym Bike Med, Technogym, Gambettola, Italy), 
using an Oxycon Pro gas analysis system (Jaeger, Friedberg, Germany). For testing, the protocol described by 
Achten et al.53 was adapted. The protocol had two phases: (a) a 4-minute warm-up at 40 watts, followed by 
increases of 20 watts every 3  minutes, maintaining a cadence of 60 rotations per minute until the respiratory 
exchange ratio reached 1.0; and, (b) a second phase that started at this moment, and that consisted of increments 
of 20 watts every minute, maintaining a cadence between 70–80 rotations per minute, until volitional fatigue. The 
VO2peak was calculated as the average of the highest 30  seconds of oxygen uptake. The VO2peak was expressed in 
absolute values (l∙min−1) and normalized to the total body weight (ml∙kg−1 ∙ min−1).
Cardio-metabolic risk factors. Cardio-metabolic risk factors were measured between 8:00–9:00 AM, after at least 
10  hours of fasting. Exercise was forbidden in the 48  hours prior to the test. Blood pressure was measured using 
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a digital sphygmomanometer (Microlife WatchBP Home, Heerbrugg, Switzerland), according to established rec-
ommendations54. Capillary blood samples were taken to analyze blood glucose and total cholesterol using a port-
able multi-analyzer (Accutrend GCT, Roche Diagnostics, Mannheim, Germany).
Cardiovascular risk. The SCORE risk charts of the European Society of Cardiology55 were used to estimate the 
10-year coronary risk. The formula uses total cholesterol, systolic blood pressure, gender, age, and smoking sta-
tus55. In addition, cardiovascular risk was also estimated using waist-to-height ratio56.
Health-related quality of life. The health-related quality of life was measured by the Short Form Health Survey 36 
(SF-36)57, in its version adapted to the Spanish context58. This questionnaire measures physical and mental health 
through 8 scales, the scores of which are transformed to values between 0–100 points, with the highest scores 
meaning a better function. These 8 scales are grouped into two summary components, the physical summary 
component, and the mental summary component59, which were calculated according to the reference values of 
the Spanish population60, with a mean of 50 and a standard deviation of 10.
Statistical analysis. The statistical package SPSS 22.0 (SPSS Inc., Chicago, IL, USA) was used to analyze the 
data. Graphs were drawn with Sigmaplot v.11.0 (Systat Software, Inc.). The Kolmogorov-Smirnov test was used to 
determine if the data were normally distributed. A one-way repeated measurements ANOVA was used to evaluate 
the influence of time on body composition and CVR factors intragroup. In addition, the paired T-test was used to 
analyze the intra-group changes in health-related quality of life and in physical fitness during exercise program. 
In the cases in which the variable did not show a normal distribution, a Wilcoxon paired test was used. For the 
inter-group comparisons, the one-way ANOVA was used. The associations between body composition and CVR 
factors were performed using Pearson’s bivariate correlation analysis. To calculate the Effect Size, the Cohen’s d 
was used and was interpreted as follows: 0.20–0.50 (small), 0.50–0.80 (medium), >0.80 (large)61. Significant dif-
ferences were considered when p < 0.05. Unless otherwise indicated, data are presented as mean ± SD.
Blood pressure and CVR of one participant of the EG were eliminated in the last measurement because she 
began to take antihypertensive medication.
Data availability
All data are available from the corresponding author (M-R) upon reasonable request.
Received: 24 September 2019; Accepted: 4 February 2020;
Published: xx xx xxxx
References
 1. Reinhold, R. B. Critical analysis of long term weight loss following gastric bypass. Surg. Gynecol. Obstet. 155, 385–94 (1982).
 2. Ricci, C., Gaeta, M., Rausa, E., Macchitella, Y. & Bonavina, L. Early impact of bariatric surgery on type II diabetes, hypertension, and 
hyperlipidemia: a systematic review, meta-analysis and meta-regression on 6,587 patients. Obes. Surg. 24, 522–8 (2014).
 3. Magro, D. O. et al. Long-term weight regain after gastric bypass: A 5-year prospective study. Obes. Surg. 18, 648–651 (2008).
Block 1 Block 2 Block 3 Block 4 Block 5
Sessions per week 2 3 4 4 4
Resistance training
2 d/w 2 d/w 2 d/w 2 d/w 2 d/w
1 set 1 set 4 sets 4 sets 4 sets
5 exercises 7 exercises 4 exercises 4 exercises 4 exercises
20 repetitions 20 repetitions 15 repetitions 12 repetitions 10 repetitions
~50% RM ~60% RM ~65% RM ~70% RM ~75% RM
8  min 12  min 28  min 26  min 24  min
Endurance training
HIIT
— 2 d/w 2 d/w 2 d/w 2 d/w
60–70% VO2peak 70–80% VO2peak 75–85% VO2peak 80–95% VO2peak
20  min 20  min 20  min 20  min
ACT
2 d/w 1 d/w 2 d/w 2 d/w 2 d/w
60–70% HRmax 70–75% HRmax 70–80% HRmax 70–80% HRmax 70–80% HRmax
35  min 50  min 50  min 50  min 50  min
Stretching training
2 d/w 2 d/w 2 d/w 2 d/w 2 d/w
4 exercises 4 exercises 4 exercises 4 exercises 4 exercises
1  min per exercise 1  min per exercise 1  min per exercise 1  min per exercise 1  min per exercise
Table 4. Exercise program performed by the experimental group. d/w indicates days per week; RM, repetition 
maximum; ACT, aerobic continuous training; HRmax, maximal heart rate; HIIT, high intensity interval training; 
VO2peak, peak oxygen uptake. Blocks 1 and 2 were considered as a progressive adaptation. During the second 
half of block 3, the participants were evaluated and the new values of RM and VO2peak were used to prescribe 
the exercise intensity from that moment on. HIIT, resistance training and stretching were combined in the same 
session. Therefore, independently of its modality (concurrent vs aerobic continuous exercise), every session had 
a similar duration (≈50  min).
9Scientific RepoRtS |         (2020) 10:3123  | https://doi.org/10.1038/s41598-020-60044-z
www.nature.com/scientificreportswww.nature.com/scientificreports/
 4. Freire, R. H., Borges, M. C., Alvarez-Leite, J. I. & Toulson Davisson Correia, M. I. Food quality, physical activity, and nutritional 
follow-up as determinant of weight regain after Roux-en-Y gastric bypass. Nutrition 28, 53–8 (2012).
 5. Felsenreich, D. M. et al. Weight loss, weight regain, and conversions to Roux-en-Y gastric bypass: 10-year results of laparoscopic 
sleeve gastrectomy. Surg. Obes. Relat. Dis. 12, 1655–1662 (2016).
 6. Bohdjalian, A. et al. Sleeve gastrectomy as sole and definitive bariatric procedure: 5-Year results for weight loss and ghrelin. Obes. 
Surg. 20, 535–540 (2010).
 7. Lemanu, D. P. et al. Five-year results after laparoscopic sleeve gastrectomy: A prospective study. Surg. Obes. Relat. Dis. 11, 518–524 
(2015).
 8. Himpens, J., Dobbeleir, J. & Peeters, G. Long-term results of laparoscopic sleeve gastrectomy for obesity. Ann. Surg. 252, 319–324 
(2010).
 9. Alexandrou, A. et al. Laparoscopic sleeve gastrectomy for morbid obesity: 5-year results. Am. J. Surg. 209, 230–234 (2015).
 10. Shah, M., Simha, V. & Garg, A. Review: Long-term impact of bariatric surgery on body weight, comorbidities, and nutritional status. 
J. Clin. Endocrinol. Metab. 91, 4223–4231 (2006).
 11. Alvarez, V. et al. Mechanisms of long-term weight regain in patients undergoing sleeve gastrectomy. Nutrition 32, 303–308 (2016).
 12. Odom, J. et al. Behavioral Predictors of Weight Regain after Bariatric Surgery. Obes. Surg. 20, 349–356 (2010).
 13. Livhits, M. et al. Patient behaviors associated with weight regain after laparoscopic gastric bypass. Obes. Res. Clin. Pract. 5, e258–e265 
(2011).
 14. Herring, L. Y. et al. Changes in physical activity behaviour and physical function after bariatric surgery: A systematic review and 
meta-analysis. Obes. Rev. 17, 250–261 (2016).
 15. Josbeno, D. A., Kalarchian, M., Sparto, P. J., Otto, A. D. & Jakicic, J. M. Physical Activity and Physical Function in Individuals Post-
bariatric Surgery. Obes Surg 21, 1243–1249 (2011).
 16. Kennedy, L. Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years After Bariatric. Surgery. Yearb. Med. 2006, 466–469 (2006).
 17. Otto, M. et al. Sleeve Gastrectomy and Roux-en-Y Gastric Bypass Lead to Comparable Changes in Body Composition after 
Adjustment for Initial Body Mass Index. Obes. Surg. 26, 479–485 (2015).
 18. Coleman, K. J. et al. Three-year weight outcomes from a bariatric surgery registry in a large integrated healthcare system. Surg. Obes. 
Relat. Dis. 10, 396–403 (2014).
 19. Blume, C. A. et al. Nutritional profile of patients before and after Roux-en-Y gastric bypass: 3-year follow-up. Obes. Surg. 22, 
1676–1685 (2012).
 20. Biagioni, M. F. G. et al. Bariatric Roux-En-Y Gastric Bypass Surgery: Adipocyte Proteins Involved in Increased Bone Remodeling in 
Humans. Obes. Surg. 25, 2376–2385 (2017).
 21. Lubrano, C. et al. Reduction of risk factors for cardiovascular diseases in morbid-obese patients following biliary-intestinal bypass: 
3 years’ follow-up. Int. J. Obes. Relat. Metab. Disord. 28, 1600–6 (2004).
 22. Laguna, S. et al. Las variaciones en colesterol-HDL tras bypass gástrico proximal son independientes de la evolución ponderal. An. 
Sist. Sanit. Navar. 39, 23–33 (2016).
 23. Sumithran, P. & Proietto, J. The defence of body weight: a physiological basis for weight regain after weight loss. Clin Sci (Lond). 124, 
231–41 (2013).
 24. Sjöström, L. et al. Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery. N. Engl. J. Med. 351, 
2683–2693 (2004).
 25. Browning, M. G., Franco, R. L., Cyrus, J. C., Celi, F. & Evans, R. K. Changes in Resting Energy Expenditure in Relation to Body 
Weight and Composition Following Gastric Restriction: A Systematic Review. Obes. Surg. 26, 1607–1615 (2016).
 26. Faria, S. L., Kelly, E. & Faria, O. P. Energy Expenditure and Weight Regain in Patients Submitted to Roux-en-Y Gastric Bypass. Obes. 
Surg. 19, 856–859 (2009).
 27. Herman, K. M., Carver, T. E., Christou, N. V. & Andersen, R. E. Keeping the weight off: Physical activity, sitting time, and weight loss 
maintenance in bariatric surgery patients 2 to 16 years postsurgery. Obes. Surg. 24, 1064–1072 (2014).
 28. Herring, L. Y. et al. The effects of supervised exercise training 12 – 24 months after bariatric surgery on physical function and body 
composition: a randomised controlled trial. Int J Obes 41, 909–916 (2017).
 29. Wang, X. et al. Weight Regain is Related to Decreases in Physical Activity During Weight Loss. Med Sci Sport. Exerc 40, 1781–1788 
(2009).
 30. Anastasiou, C. A., Karfopoulou, E. & Yannakoulia, M. Weight regaining: From statistics and behaviors to physiology and 
metabolism. Metabolism: Clinical and Experimental 64, 1395–1407 (2015).
 31. Arterburn, D. E. et al. A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes. 
Surg. 23, 93–102 (2013).
 32. Brethauer, S. A. et al. Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 
2 diabetes mellitus. Ann. Surg. 258, 628–36; discussion 636-7 (2013).
 33. Jimenez, A. et al. Long-Term Effects of Sleeve Gastrectomy and Roux-en-Y Gastric Bypass Surgery on Type 2 Diabetes Mellitus in 
Morbidly Obese Subjects. Ann.Surg. 256, 1023–1029 (2012).
 34. National Cholesterol Education Program. Third report of the National Cholesterol Education Program (NCEP) expert panel on 
detection, evaluation, and treatment of high blood cholesterol in adults. Circulation 17, 3147–3421 (2002).
 35. Daugaard, J. R. & Richter, E. A. Relationship between muscle fibre composition, glucose transporter protein 4 and exercise training: 
possible consequences in non-insulin-dependent diabetes mellitus. Acta Physiol. Scand. 171, 267–276 (2001).
 36. Sylow, L., Kleinert, M., Richter, E. A. & Jensen, T. E. Exercise-stimulated glucose uptake - regulation and implications for glycaemic 
control. Nat. Rev. Endocrinol. 13, 133–148 (2017).
 37. Hood, M. S., Little, J. P., Taoplsky, M. A., Frank, M. & Gibala, M. J. Low-volume interval training improves muscle oxidative capacity 
in sedentary adults. Med Sci Sport. Exerc 43, 1849–1856 (2011).
 38. Little, J. P. et al. Low-volume high-intensity interval training reduces hyperglycemia and increases muscle mitochondrial capacity in 
patients with type 2 diabetes. J. Appl. Physiol. 111, 1554–1560 (2011).
 39. Houmard, J. A., Pories, W. J. & Dohm, G. L. Severe obesity: evidence for a deranged metabolic program in skeletal muscle? Exerc 
Sport Sci Rev 40, 204–210 (2013).
 40. Kelley, D. E. Skeletal muscle fat oxidation: timing and flexibility are everything. J. Clin. Invest. 115, 1699–1702 (2005).
 41. Jelleyman, C. et al. The effects of high-intensity interval training on glucose regulation and insulin resistance: A meta-analysis. Obes. 
Rev. 16, 942–961 (2015).
 42. Ashwell, M., Gunn, P. & Gibson, S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult 
cardiometabolic risk factors: Systematic review and meta-analysis. Obesity Reviews 13, 275–286 (2012).
 43. Omotosho, P., Mor, A., Shantavasinkul, P. C., Corsino, L. & Torquati, A. Gastric bypass significantly improves quality of life in 
morbidly obese patients with type 2 diabetes. Surg. Endosc. 30, 2857–64 (2016).
 44. King, W. C. et al. Change in Pain and Physical Function Following Bariatric Surgery for Severe Obesity. Jama 315, 1362–1371 (2016).
 45. Strain, G. W. et al. Cross-sectional review of effects of laparoscopic sleeve gastrectomy at 1, 3, and 5 years. Surg. Obes. Relat. Dis. 7, 
714–719 (2011).
 46. Zdziarski, L. A., G, W. J. & Vincent, H. K. Chronic pain management in the obese patient: a focused review of key challenges and 
potential exercise solutions. J Pain Res. 9, 63–77 (2015).
1 0Scientific RepoRtS |         (2020) 10:3123  | https://doi.org/10.1038/s41598-020-60044-z
www.nature.com/scientificreportswww.nature.com/scientificreports/
 47. Marc-Hernández, A., Ruiz-Tovar, J., Aracil, A., Guillén, S. & Moya-Ramón, M. Impact of Exercise on Body Composition and 
Cardiometabolic Risk Factors in Patients Awaiting Bariatric Surgery. Obes. Surg. 1–10 https://doi.org/10.1007/s11695-019-04088-9 
(2019).
 48. Brzycki, M. Strength Testing—Predicting a One-Rep Max from Reps-to-Fatigue. J. Phys. Educ. Recreat. Danc. 64, 88–90 (1993).
 49. Kyle, U. G. et al. Bioelectrical impedance analysis - Part II: Utilization in clinical practice. Clin. Nutr. 23, 1430–1453 (2004).
 50. National Institutes of Health. National Heart, Lung, and B. I. Clinical guidelines on the identification, evaluation, and treatment of 
overweight and obesity in adults. The Evidence Report. Obes. Res. 6, 51S–209S (1998).
 51. Deitel, M. & Greenstein, R. Recommendations for Reporting Weight Loss. Obes. Surg. 13, 159–160 (2003).
 52. Stewart, A., Marfell-Jones, M., Olds, T. & Ridder, H. de. International Standards for Anthropometric Assessment. (International 
Society for the Advancement of Kinanthropometry, 2011).
 53. Achten, J., Gleeson, M. & Jeukendrup, A. E. Determination of the exercise intensity that elicits maximal fat oxidation. Med. Sci. 
Sports Exerc. 34, 92–7 (2002).
 54. Pickering, T. G. et al. Recommendations for Blood Pressure Measurement in Humans and Experimental Animals: Part 1: Blood 
Pressure Measurement in Humans: A Statement for Professionals From the Subcommittee of Professional and Public Education of 
the American Heart Association Cou. Hypertension 45, 142–161 (2005).
 55. Piepoli, M. F. et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. European Heart Journal 37, 
2315–2381 (2016).
 56. Félix-Redondo, F. J. et al. Prevalence of obesity and associated cardiovascular risk: the DARIOS study. BMC Public Health 13, 542 
(2013).
 57. Ware, J. E., Snow, K. K., Kosinski, M. & Gandek, B. SF-36 health survey: manual and interpretation guide. (1993).
 58. Alonso, J., Prieto, L. & Antó, J. M. La versión española del SF-36 Health Survey (Cuestionario de Salud SF-36): un instrumento para 
la medida de los resultados clínicos. Med. Clin. 104, 771–776 (1995).
 59. Ware, J. E., Snow, K. K., Kosinski, M. & Gandek, B. SF-36 physical and mental health summary scales: a user’s manual. (Health 
Institute New England Medical Center, 1994).
 60. Alonso, J. et al. Valores poblacionales de referencia de la versión Española del cuestionario de salud SF-36. Med. Clin. (Barc). 111, 
410–416 (1998).
 61. Cohen, J. Statistical Power Analysis for the Behavioral Sciences. (Routledge, 2013).
Acknowledgements
This study was made possible by the research agreements between the Vinalopó Hospital (Ref.: 
VINALOPOSALUD2.16X) and Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la 
Comunidad Valenciana (Ref.: FISABIO3.15X- anexo 4), with the Miguel Hernández University.
Author contributions
A.A. and M.M.-R. designed the study; A.M.-H. developed the intervention and drafted the paper; A.M.-H. and 
S.G. performed the evaluations and obtained the data; A.M.-H. and A.A. analysed the data and made the tables 
and figures; A.A. reviewed the first draft; J.R.-T. provided critical comments to the design and to the first draft; 
M.M.-R. directed the study, assigned participants to the corresponding group, supervised the obtention of data 
and the manuscript writing, and corrected the final version of the manuscript. All the authors contributed to the 
final writing of the manuscript and approved it.
Competing interests
The authors declare no competing interests.
Additional information
Supplementary information is available for this paper at https://doi.org/10.1038/s41598-020-60044-z.
Correspondence and requests for materials should be addressed to A.A. or M.M.-R.
Reprints and permissions information is available at www.nature.com/reprints.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2020
